DNA adducts from chemotherapeutic agents

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 355, Issue 1-2, 1996, Pages 13-40

  Lawley, P D ^a   Phillips, D H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

anticancer drugs; DNA adduct; DNA cross link; DNA repair

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; LOMUSTINE; MELPHALAN; METHOXSALEN; MITOMYCIN; MUSTARD GAS; PROCARBAZINE;

ANIMAL CELL; DNA ADDUCT; DNA ALKYLATION; DNA CROSS LINKING; DNA REPAIR; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA; MAMMALIA;

EID: 0030591663     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(96)00020-6     Document Type: Article

References (174)

1. Adair, F.E. and H.J. Bagg (1931) Experimental and clinical studies on the treatment of cancer by dichloroethyl sulfide (mustard gas), Ann. Surgery, 93, 190-199.
2. Armstrong, S.G., G.P. Browman, A.M. Benger, R.M. Meyer, K.L. McKay and G. Singh (1994) Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia. Leukemia Res., 18, 659-664.
3. Arnold, H. and F. Bourseaux (1958) Synthese und Abbau cytostatisch wirksamer cyclischer N-Phosphamidester des Bis(β-chloroäthyl)amins, Angew. Chem., 70, 539-544.
4. Avery, O.T., C.M. MacLeod and M. McCarty (1944) Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid traction isolated from pneumococcus Type III, J. Exp Med., 79, 137-158.
5. Bagshawe, K.D. (1994) Antibody-directed enzyme pro-drug therapy, Clin. Pharmacother., 27, 368-376.
6. Ball, C.R. and J.J. Roberts (1970) DNA repair after mustard gas alkylation by sensitive and resistant Yoshida sarcoma cells in vitro, Chem.-Biol. Interactions, 2, 321-329.
7. Ball, C.R. and J.J. Roberts (1971/72) Estimation of interstrand DNA cross-linking resulting from mustard gas alkylation of HeLa cells, Chem.-Biol. Interactions, 4, 797-303.
8. Bank, B.B., D. Kanganis, L.F. Liebes and R. Silber (1989) Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes, Cancer Res., 49, 554-559.
9. Bedford, P., A.M.J. Fichtinger-Schepman, S.A. Shellard, M.C. Walker, J.R.W. Masters and B.T. Hill (1988) Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines, Cancer Res., 48, 3019-3024.
10. Berends, W. (1961) On the dimerisation in nucleic acids as a result of ultraviolet irradiation, J. Chem. Phys., 58, 1034-1040.
11. Bergel, F. and J.A. Stock (1954) Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines, J. Chem. Soc., 2409-2417.
12. Bhat, H.K., X. Han, A. Gladek and J.G. Liehr (1994) Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure, Carcinogenesis, 15, 2137-2142.
13. Biedler, J.L. (1992) Genetic aspects of multidrug resistance, Cancer, 70, 1799-1809.
14. Blommaert, F.A., C. Michael, P.M.A.B. Terheggen, F.M. Muggia, V. Kortes, J.H. Schornagel, A.A.M. Hart and L. den Engelse (1993) Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response, Cancer Res., 53, 5669-5675.
15. Bohr, V.A. (1994) Gene-specific damage and repair of DNA adducts and cross-links, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar and H. Bartsch (Eds.). DNA Adducts: Identification and Biological Significance, IARC Scientific Publication No. 125, IARC, Lyon, pp. 361-369.
16. Borowy-Borowski, H., R. Lipman and M. Tomasz (1990) Recognition between mitomycin C and specific DNA sequences for cross-link formation. Biochemistry, 29, 2999-3004.
17. Boyce, R.P. and P. Howard-Flanders (1964) Release of ultraviolet light-induced thymine dimers from DNA in E. coli K-12, Proc. Natl. Acad. Sci. USA, 51, 293-300.
18. Brock, N. and H.J. Hohorst (1963) On the activation of cyclophosphamide in vivo and in vitro, Arzneimittel-Forschung, 29, 659-661.
19. Brookes, P. (1965) Studies on the mode of action of ibenzmethyzin, in: A.M. Jelliffe and J. Marks (Eds.), Natulan (Ibenzmethyzin), Report of Proceedings of a Symposium held at Downing College, Cambridge, on 22 June, 1965, sponsored by Roche Products Ltd., J. Wright & Sons, Bristol, pp. 9-12.
20. Brookes, P. and P.D. Lawley (1960) The reaction of mustard gas with nucleic acids in vitro and in vivo, Biochem. J., 77, 478-484.
21. Brookes, P. and P.D. Lawley (1961) The reaction of mono-and di-functional alkylating agents with nucleic acids, Biochem. J., 80, 496-503.
22. Brookes, P. and P.D. Lawley (1964) Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to DNA, Nature (Lond.), 202, 781-784.
23. Brookes, P. and P.D. Lawley (1965) In vivo reactions of isotopically labelled alkylating agents, in: L.J. Roth (Ed.), Isotopes in Experimental Pharmacology, University of Chicago Press, pp. 403-414.
24. Calvert, A.H., S.J. Harland, D.R. Newell, Z.H. Siddik, A.C. Jones, T.J. McElwain, S. Raju, E. Wiltshaw, I.E. Smith, J.M. Baker, M.J. Peckham and K.R. Harrap (1982) Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II, Cancer Chemother. Pharmacol., 9, 140-147.
25. Cole, R.S. (1973) Repair of DNA containing interstrand cross-links in Escherichia coli: sequential excision and recombination, Proc. Natl. Acad. Sci. USA, 70, 1064-1068.
26. Crathorn, A.R. and J.J. Roberts (1966) Mechanism of the cytotoxic action of alkylating agents in mammalian cells and evidence for the removal of alkylated groups from deoxyribonucleic acid, Nature (Lond.), 211, 150-153.
27. den Engelse, L., J. van Benthem and E. Scherer (1990) Immunocytochemical analysis of in vivo DNA modification, Mutation Res., 233, 265-287.
28. Dabholkar, M., L. Bradshaw, R.J. Parker, I. Gill, F. Bostick-Bruton, P.M. Muggia and E. Reed (1992) Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro, Environ. Health Perspect., 98, 53-59.
29. DeVita, V.T., P.P. Carbone, A.H. Owens, G.L. Gold, Krant, M.J. and J. Edmonson (1965) Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962, Cancer Res., 25, 1876-1881.
30. Dipple, A., P. Brookes, D.S. Mackintosh and M.P. Rayman (1971) Reaction of 7-bromomethylbenz[α]anthracene with nucleic acids, nucleotides and nucleosides, Biochemistry, 10, 4323-4330.
31. Eastman, A. (1983) Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II), Biochemistry, 22, 3927-3933.
32. Emanuel, N.M., E.M. Vermel, L.A. Ostrovskaya and N.P. Korman (1974) Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909), Cancer Chemother. Reports, Part 1, 58, 135-148.
33. Everett, J.L., J.J. Roberts and W.C.J. Ross (1953) Aryl-2-halogenoalkylamines. Part XII. Some carboxylic derivatives of N,N-di-2-chloroethylaniline, J. Chem. Soc., 2386-2392.
34. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea, Cancer Chemother. Pharmacol., 32, 471-476.
35. Fichtinger-Schepman, A.M.J., P.M. Lohman and J. Reedijk (1982) Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum(II) with DNA, by anion-exchange chromatography after enzymatic degradation, Nucleic Acids Res., 10, 5345-5356.
36. Fichtinger-Schepman, A.M.J., P.H.M. Lohman and F. Berends (1986) Interactions of the antitumour drug cisplatin with DNA in vitro and in vivo, in: D. Schmähl and J.M. Kaldor (Eds.), Carcinogenicity of Alkylating Cytostatic Drugs. IARC Scientific Publications No. 78, IARC, Lyon, pp. 83-99.
37. Fichtinger-Schepman, A.M.J., A.T. van Oosterom, P.H.M. Lohman and F. Berends (1987) Cis-diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients. Quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatnum(II), Cancer Res., 47, 3000-3004.
38. Fichtinger-Schepman, A.M.J., S.D. van der Velde-Visser, H.C.M. van Dijk-Knijnenburg, A.T. van Oosterom, R.A. Baan and F. Berends (1990) Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation, Cancer Res., 50, 7887-7894.
39. Fidder, A., G.W.H. Moes, A.G. Scheffer, G.P. van der Schans, R.A. Baan, L.P.A. de Jong and H.P. Benschop (1994) Synthesis, characterization, and quantitation of the major adducts formed between sulfur mustard and DNA of calf thymus and human blood, Chem. Res. Toxicol., 7, 199-204.
40. Fraval, H.N.A., C.J. Rawlings and J.J. Roberts (1978) Increased sensitivity of u.v.-repair-deficient human cells to DNA-bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from micrococcus luteus, Mutation Res., 51, 121-132.
41. Geiduschek, E.P. (1965) Reversible DNA, Proc. Natl. Acad. Sci. USA, 47, 950-955.
42. Geleziunas, R., A. McQuillan, A. Malapiesa, M. Hutchinson, D. Kopriva, M.A. Wainberg, J. Hiscott, J. Bramson, and L. Panasci (1991) Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards, J. Natl. Cancer Inst., 83, 557-564.
43. Gill, I., F.M. Muggia, P.M.A.B. Terheggen, C. Michael, R.J. Parker, V. Kortes, S. Grunberg, M.C. Christian, E. Reed and L. den Engelse (1991) Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum adducts, Ann. Oncol., 2, 115-121.
44. Gilman, A. and F.S. Philips (1946) The biological actions and therapeutic applications of the β-chloroethyl amines and sulfides, Science, 103, 409-415.
45. Goldacre, R.J., Loveless, A. and Ross, W.C.J. (1949) Mode of production of chromosome abnormalities by nitrogen mustards: possible role of cross-linking, Nature (Lond.), 163, 667-669.
46. Goldenberg, G.J., M. Lee, P.H.-Y. Lam and A. Begleiter (1977) Evidence for carrier-mediate transport of melphalan by L5178Y lymphoblasts in vitro, Cancer Res., 37, 755-760.
47. Gupta-Burt, A., H. Shamkhani, E. Reed, R.E. Tarone, C.J. Allegra, L.H. Pai and M.C. Poirier (1993) Relationship between patient response in ovarian and breast cacer and platinum drug-DNA adduct formation, Cancer Epidemiol., Biomarkers Prevent., 2, 229-234.
48. Han, X. and Liehr, J.G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen, Cancer Res., 52, 1300-1303.
49. Hansson, J., R. Lewensohn, U. Ringborg and B. Nilsson (1987) Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells, Cancer Res., 47, 2631-2637.
50. 6-methyl-and N7-methyldeoxyguanosine-3″-monophosphates in human DNA, Carcinogenesis, 15, 2485-2490.
51. Hashimoto, Y. and Shudo, K. (1985) Chemical modification of DNA with muta-carcinogens. III. Reductive alkylation of DNA with mitomycin C, Environ. Health Perspect., 62, 219-222.
52. Hemminki, K. (1985) Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice, Cancer Res., 45, 4237-4243.
53. Hemminki, K. (1987) DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide, Chem.-Biol. Interactions, 61, 75-88.
54. Hemminki, K. (1994) DNA adducts of nitrogen mustards and ethylene imines, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar and H. Bartsch (Eds.), DNA Adducts: Identification and Biological Significance, IARC Scientific Publication No. 125, IARC, Lyon, pp. 313-321.
55. 32P-post-labelling of 7-methyl-dGMP, ring-opened 7-methyl-dGMP and platinated dGpG, Chem.-Biol. Interactions, 74, 45-54.
56. Henderson, C.E., G. Elia, D. Garfinkel, M.C. Poirier, H. Shamkhani and C.D. Runowicz (1993) Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary, Gynecol. Oncol., 49, 92-94.
57. Herron, D.C. and R.C. Shank (1980) Methylated purines in human liver after probable dimethyinitosamine, Cancer Res., 40, 3116-3117.
58. Hopkins, P.B., J.T. Millard, J. Woo, M.F. Weidner, J.J. Kirchner, S.T. Sigurdsson and S. Raucher (1991) Sequence preferences of DNA interstrand cross-linking agents: importance of minimal DNA structural reorganization in the cross-linking reactions of mechlorethamine, cisptatin, and mitomycin C, Tetrahedron, 47, 2475-2489.
59. Huang, J.-C., D.S. Hsu, A. Kazantsev and A. Sancar (1994) Substrate spectrum of human exinuclease repair of abasic sites, methylated bases, mismatches, and bulky adducts, Proc. Natl. Acad. Sci. USA, 91, 12213-12217.
60. Iyer, V.N. and W. Szybalski (1963) A molecular mechanism of mitomycin action: linking of complementary DNA strands, Proc. Natl. Acad. Sci. USA, 50, 355-362.
61. Iyer, V.N. and W. Szybalski (1964) Mitomycins and porfiromycin; chemical mechanisms of activation and cross-linking of DNA, Science, 145, 55-58.
62. Jeggo, P. (1979) Isolation and characterization of E. coli K12 mutants unable to induce the adaptive response to simple alkylating agents, J. Bacteriol., 139, 783-791.
63. 2 and DNA in vitro, Biochem. Biophys. Res. Commun., 104, 1394-1400.
64. Karran, P. and M. Bignami (1994) DNA damage tolerance, mismatch repair and genome instability, BioEssays, 16, 833-839.
65. Karran, P., T. Lindahl, I. Øfsteng, G.B. Evenson and E. Seeberg (1980) Escherichia coli mutants deficient in 3-methyladenine-DNA glycosylase, J. Mol. Biol., 140, 101-127.
66. Kataoka, S., M. Naito, A. Toida and T. Tsuruo (1994) Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells, Exp. Cell Res., 215, 199-205.
67. 32P-postlabeling analysis, Mutation Res., 20, 85-91.
68. Knox, R.J., F. Friedlos, D.A. Lydall and J.J. Roberts (1986) Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA, Cancer Res., 46, 1972-1979.
69. Knox, R.J., D.A. Lydall, F. Friedlos, C. Basham, C.J. Rawlings and J.J. Roberts (1991) The Walker 256 carcinoma: a cell type inherently sensitive only to those difunctional agents that can form DNA interstrand crosslinks, Mutation Res., 255, 227-240.
70. Koc, O.N., M. McFee, E. Reed and S.L. Gerson (1994) Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure, Eur. J. Cancer, 30A, 716-717.
71. Kohn, K.W. and C.L. Spears (1967) Alkylated DNA: buoyant density changes and modes of decomposition, Biochim. Biophys. Acta, 145, 720-733.
72. Kohn, K.W., N.H. Steigbigel and C.L. Spears (1965) Cross-linking and repair of DNA in sensitive and resistant strains of E. coli treated with nitrogen mustard, Proc. Natl. Acad. Sci. USA, 53, 1154-1161.
73. Kohn, K.W., C.L. Spears and P. Doty (1966) Interstrand cross-linking of DNA by nitrogen mustard, J. Mol. Biol., 19, 266-288.
74. Kolaric', K. (1977) Combination chemotherapy with 1-methyl-1-nitrosourea (MNU) and cyclophosphamide in solid tumours, Z. Krebsforschung, 89, 311-319.
75. Krumbhaar, E.B. and H.D. Krumbhaar (1919) The blood and bone marrow in yellow cross gas (mustard gas) poisoning: changes produced in the bone marrow of fatal cases, J. Med. Res., 40, 497-507.
76. 6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects. Environ. Health Perspect., 99, 143-147.
77. Lawley, P.D. (1984) Carcinogenesis by alkylating agents, in: C.E.Searle (Ed.) Chemical carcinogens, 2nd Edn., Vol. 1, ACS Monograph 182, American Chemical Society, Washington, pp. 325-484.
78. Lawley, P.D. (1990) N-Nitroso compounds, in: C.S. Cooper and P.L. Grover (Eds.), Chemical Carcinogenesis and Mutagenesis I, Handbook of Experimental Pharmacology, 94/1, pp. 409-469.
79. Lawley, P.D. and P. Brookes (1965) Molecular mechanism of cytotoxic action of difunctional alkylating agents and of resistance to this action. Nature (Lond.), 206, 480-483.
80. Lawley, P.D. and P. Brookes (1968) Cytotoxicity of alkylating agents towards sensitive and resistant strains of Escherichia coli in relation to extent and mode of alkyiation of cellular macromolecules and repair of alkyiation lesions in DNA. Biochem. J., 109, 433-447.
81. Lawley, P.D. and D.J. Orr (1970) Specific excision of methylation products from DNA of Escherichia coli treated with N-methyl-N″-nitro-N-nitrosoguanidine, Chem.-Biol. Interactions, 2, 154-157.
82. Lawley, P.D. and S.A. Shah (1972) Reaction of alkylating mutagens and carcinogens with nucleic acids: detection and estimation of a small extent of methylation at O-6 of guanine in DNA by methyl methanesulfonate in vitro, Chem.-Biol. Interactions, 5, 286-288.
83. 14C-methyl-labelled N-methyl-N-nitrosourea: evidence for transfer of the intact methyl group, Chem.-Biol. Interactions, 7, 115-120.
84. Lawley, P.D. and C.J. Thatcher (1970) Methylation of DNA in cultured mammalian cells by N-melthyl-N″-nitro-N-nitrosoguanidine: the influence of cellular thiol concentrations on the extent of methylation and the 6-oxygen atom of guanine as a site of methylation, Biochem. J., 116, 693-707.
85. Lawley, P.D., J.H. Lethbridge, P.A. Edwards and K.V. Shooter (1969) Inactivation of bacteriophage T7 by mono-and di-functional sulphur mustards in relation to cross-linking and depurination of bacteriophage DNA, J. Mol. Biol., 39, 181-198.
86. 6-methylguanine and 3-methyladenine, Chem.-Biol. Interactions, 57, 107-121.
87. Los, G., E. Verdegaal, H.P.J.M. Noteborn, M. Ruevekamp, A. de Graeff, E.W. Meesters, D.T.B. Huinink and J.G. McVie (1991) Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action, Biochem. Pharmacol., 42, 357-363.
88. 6-alkylation of deoxyguanosine to mutagenicity and carcinogenicity of nitrosamines and nitrosamides, Nature (Lond.), 223, 206-207.
89. Ludlum, D.B. (1986) Nature and biological significance of DNA modification by the haloethylnitrosoureas, in: D. Schmähl and J.M. Kaldor (Eds.), Carcinogenicity of Alkylating Cytostatic Drugs, IARC Scientific Publication No, 78, IARC, Lyon, pp. 71-81.
90. 6-alkylguanine alkyltransferase, Carcinogenesis, 7, 1203-1206.
91. 6-alkylguanine-DNA alkyltransferase, Cancer Res., 46, 3353-3357.
92. Ludlum, D.B., P. Austin-Ritchie, M. Hagopian, T.-Q. Niu and D. Yu (1994) Detection of sulfur mustard-induced DNA modifications, Chem.-Biol. Interactions, 91, 39-49.
93. Marcelis, A.T.M. and J. ReediJk (1983) Binding of platinum compounds to nucleic acids with respect to the anti-tumor activity of cis-diamminedichloroplatinum(II) and derivatives, Rec. Trav. Chim. Pays Bas, 102, 121-129.
94. Marnett, L.J. (1994) DNA adducts of α,β-unsaturated aldehydes and dicarbonyl compounds, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar, D. Segerback and H. Bartsch (Eds.), DNA Adducts: Identification and Biological Significance, IARC Scientific Publication No. 125, IARC, Lyon, pp. 151-163.
95. McDiarmid, M.A., P.T. Iype, K. Kolodner, D. Jacobson-Kram and P.T. Strickland (1991) Evidence for acrolein-modified DNA in peripheral blood leukocytes of cancer patients treated with cyclophosphamide, Mutation Res., 248, 93-99.
96. McElwain, T.J., D.W. Hedley, G. Burton,, H.M. Clink, M.Y. Gordon, M. Jarman, C.A. Juttner, J.L. Millar, R.A.V. Milsted, G. Prentice, I.E. Smith, D. Spence and M. Woods (1979) Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high dose melphalan, Br. J. Cancer, 40, 72-80
97. Millar, B.C., and J.B.G. Bell (1987) Comparison of melphalan toxicity in human lymphocytic cells and Chinese hamster cells in vitro: the relationship between DNA-DNA crosslink formation and clonogenic survival, Carcinogenesis, 8, 1225-1229.
98. Millar, B.C., J.A. Maitland, J.L. Millar and J.B.G. Bell (1989) Melphalan transport into human malignant lymphoid cells differs from the murine equivalent in vitro, Br. J. Cancer, 59, 710-713.
99. Mirkes, P.E., N.A. Brown, M. KaJbaf, J.H. Lamb, P.B. Farmer and S. Naylor (1992) Identifiication of cyclophosphamide-DNA adducts in rat embryos exposed in vitro to 4-hydroperoxycyclophosphamide, Chem. Res. Toxicol., 5, 382-385.
100. 6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation, Cancer Res., 52, 1171-1175.
101. Mol, M.A.E., G.P. van der Schans and P.H.M. Lohman (1993) Quantification of sulfur-mustard-induced cross-links and single-strand breaks in cultured human epidermal keratinocytes, Mutation Res., 294, 235-245.
102. Motzer, R.J., E. Reed, F. Perera, D. Tang, H. Shamkhani, M.C. Poirier, W.-Y. Tsai, R.J. Parker and G.J. Bosl (1994) Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay, Cancer 73, 2843-2852.
103. 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines, Carcinogenesis, 12, 1423-1431.
104. Ojwang, J.O., D.A. Gruenberg and E.L. Loechler (1989) Synthesis of a duplex oligonucleotide containing a nitrogen mustard interstrand DNA-DNA cross-link. Cancer Res., 49, 6529-6537.
105. Olsson, M. and T. Lindahl (1980) Repair of alkylated DNA in Escherichia coli, J. Biol. Chem., 255, 10569-10571.
106. Osborne, M.R. and P.D. Lawley (1993) Alkylation of DNA by melphalan with special reference to adenine derivatives and adenine-guanine cross-linking, Chem.-Biol. Interactions. 89. 49-60.
107. Osborne, M.R., D.E.V. Wilman and P.D. Lawley (I995a) Alkylation of DNA by the nitrogen mustard bis(2-chloroethyl)methylamine, Chem. Res. Toxicol., 8, 316-320.
108. Osborne, M.R., P.D. Lawley, C. Crofton-Sleigh and W. Warren (1995b) Products from alkylation of DNA in cells by melphalan: human soft tissue sarcoma cell line RD and Escherichia coli WP2, Chem.-Biol. Interactions, 97, 287-296.
109. Pai, L.H., S.M. Swain, D.J. Venzon, E. Reed, M.C. Poirier, S. Gupta-Burt, A.M. Denicoff and C.J. Allegra (1992) Therapy of patients with metastatic breast cancer with 5-fluoruracil, leucovorin and carboplatin, Anti-Cancer Drugs, 3, 463-469.
110. Pegg, A.E. and T.L. Byers (1992) Repair of DNA containing O6-alkylguanine, FASEB J., 6, 2302-2310.
111. Plooy, A.C.M., M. van Dijk and P.H.M. Lohman (1984) Induction and repair of DNA cross-links in Chinese hamster ovary cells treated with various pfatium coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity, Cancer Res., 44, 2043-2051.
112. Poirier, M.C., S.J. Lippard, L.A. Zwelling, H.M. Ushay, D. Kerrigan, C.C. Thill, R.M. Santella, D. Grunberger and S.H. Yuspa (1982) Antibodies elicited against cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro, Proc. Natl. Acad. Sci. USA, 79, 6443-6447.
113. Poirier, M.C., E. Reed, R.F. Ozols, T. Fasy and S.H. Yuspa (1987) DNA adducts of cisplatin in nucleated peripheral blood cells and tissues of cancer patients. Prog. Exp. Tumor Res., 31, 104-113.
114. Poirier, M.C., M.J. Egorin, A.M.J. Fichtinger-Schepman, S.H. Yuspa and E. Reed (1988) DNA adducts of cisplatin and carboplatin in tissues of cancer patients, in: H. Bartsch, K. Hemminki and I.K. O'Neill (Eds.), Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention, IARC Scientific Publication No. 89, IARC. Lyon, pp. 313-320.
115. Poirier, M.C., E. Reed, H. Shamkhani, R.E. Tarone and S. Gupta-Burt (1993) Platinum-DNA interactions in human tissues measured by cisplatin DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy, Environ. Health Perspect., 99, 149-154.
116. Preussmann, R., A. Von Hodenberg and H. Hengy (1969) Mechanism of carcinogenesis with 1-aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitro, Biochem. Pharmacol., 18, 1-13.
117. 32P-Analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C, Mutation Res., 179, 75-88.
118. Reed, E. (1991) Alkylating agents and platinum: is clinical resistance simply a tumor cell phenomenon? Current Opininon in Oncology, 3, 1055-1059.
119. Reed, E., S.H. Yuspa, L.A. Zwelling, R.F. Ozols and M.C. Poirier (1986) Quantitation of cisplatin-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy, J. Clin. Invest., 77, 545-550.
120. Reed, E., S. Sauerhoff and M.C. Poirier (1988) Quantitation of platinum-DNA binding after therapeutic levels of drug exposure - a novel use of graphite furnace spectrometry, Atomic Spectroscopy, 9, 93-95.
121. Reed, E., S. Gupta-Burt, C.L. Litterst and M.C. Poirier (1990) Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum(II)-modified DNA, Carcinogenesis, 11, 2117-2121.
122. Reid, B.D. and I.G. Walker (1969) The response of mammalian cells to alkylattng agents II. On the mechanism of the removal of sulfur-mustard-induced crosslinks, Biochim. Biophys. Acta, 179, 179-188.
123. Rink, S.M., M.S. Solomon, M.J. Taylor, S.B. Rajur, L.W. McLaughlin and P.B. Hopkins (1993) Covalent structure of a nitrogen-mustard-induced DNA interstrand crosslink: an N7-to-N7 linkage of deoxyguanosine residues at the duplex sequence 5″-d(GNC), J. Am. Chem. Soc., 115, 2551-2557.
124. Roberts, J.J. and F. Friedlos (1982) The frequency of interstrand cross-links in DNA following reaction of cis-diammine-dichloroplatinum(II) with cells in culture or DNA in vitro: stability of DNA cross-links and their repair, Chem.-Biol. Interactions, 39, 181-189.
125. Roberts, J.J. and J.M. Pascoe (1972) Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds, Nature (Lond.), 235, 282-284.
126. Roberts, J.J. and A.J. Thomson (1979) The mechanism of action of antitumor platinum compounds, Prog. Nucleic Acid Res, Mol. Biol., 22, 71-133.
127. Roberts, J.J., T.P. Brent and A.R. Crathorn (1971a) Evidence for the inactivation and repair of the mammalian DNA template after alkylation by mustard gas and half mustard gas, Eur. J. Cancer, 7, 515-524.
128. Roberts, J.J., J.M. Pascoe, J.E. Plant, J.E. Sturrock and A.R. Crathorn (1971b) Quantitative aspects of the repair of alkylated DNA in cultured mammalian cells I. The effect on HeLa and Chinese hamster cell survival of alkylation of cellular macromolecules, Chem.-Biol. Interactions, 3, 29-47.
129. Roberts, J.J., F. Friedlos, D. Scott, M.G. Ormerod and C.J. Rawlings (1986) The unique sensitivity of Walker rat tumour cells to difunctional agents is associated with a failure to recover from inhibition of DNA synthesis and increased chromosome damage. Mutation Res., 166, 169-181.
130. Robinson, B.A., R.D. Clutterbuck, J.L. Millar and T.J. McElwain (1985) Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow, Br. J. Cancer, 52, 813-822.
131. Rosenberg, B. (1985) Fundamental studies with cisplatin, Cancer, 55, 2303-2316.
132. Rosenberg, B., L. van Camp and T. Krigas (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode, Nature (Lond.). 205, 698-699.
133. Rydberg, B. and T. Lindahl (1982) Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction, EMBO J., 1, 211-216.
134. Santella, R.M., X.Y. Yang, V.A. DeLeo and F.P. Gasparro (1988) Detection and quantification of 8-methoxypsoralen-DNA adducts, in: H. Bartsch, K. Hemminki and I.K. O'Neill (Eds.), Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention, IARC Scientific Publication No. 89, IARC, Lyon, pp. 333-340.
135. Selby, P.J., T.J. McElwain, A.C. Nandi, T.J. Perren, R.L. Powles, C.R. Tillyer, R.J. Osborne, M.L. Slevin and J.S. Malpas (1987) Multiple myeloma treated with high dose intravenous melphalan, Br. J. HaematoL, 66, 55-62.
136. Selby, P.J., G. Zulian, G. Forgeson, A.C. Nardi, S. Milan, M. Meldrum, C. Viner, R.J. Osborne, J.S. Malpas and T.J. McElwain (1988) The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies, Hematol. Oncol., 6, 173-179.
137. Setlow, R.B. and W.L. Carrier (1964) The disappearance of thymine dimers from DNA: an error-correcting mechanism, Proc. Natl. Acad. Sci. USA, 51, 226-231.
138. Shealy, Y.F., C.A. Krauth and J.A. Montgomery (1962) Imidazoles, I. Coupling reactions of 5-diazoimidazole-4-carboxamide, J. Org. Chem., 27, 2150-2154.
139. 32P-postlabeling assay of N7-methyldeoxyguanosine, Cancer Res., 50, 6580-6584.
140. Shooter, K.V., R. Howse, R.K. Merrifield and A.B. Robins (1972) The interaction of platinum II compounds with bacteriophages T7 and R17, Chem.-Biol. Intetactions, 5, 289-307.
141. 14C-labeled 7-methylguanine in rats and man after administration of 4(5)-(3,3,-dimethyl-1-triazeno)imidazole 5(4)-carboxamide, Toxicol. Appl. Pharmacol., 18, 707-719.
142. 6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. Carcinogenesis, 12, 285-288.
143. 6-alkylguanine-DNA-alkyltransferase repair activity in normal and neoplastic human tissues, Comp. Biochem. Physiol., 101B, 269-275.
144. Stephens, T.C., K. Adams and J.H. Peacock (1986) Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo, Br. J. Cancer, 53, 237-245.
145. Strandberg, M.C., E. Bresnick and A. Eastman (1982) The significance of DNA crosslinking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells, Chem.-Biol. Interactions, 39, 169-180.
146. Strauss, B.S. (1991) The 'A rule' of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions? BioEssays, 13, 79-84.
147. Strauss, B.S. (1992) The origin of point mutations in human tumor cells, Cancer Res., 52, 249-253.
148. Takeshima, Y., K. Inai, W.P. Bennett, R.A. Metcalf, J.A. Welsh, S. Yonehara, Y. Hayashi, M. Fujihara, M. Yamakido, M. Akiyama, S. Tokuoka, C.E. Land and C.C. Harris (1994) p53 Mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis, 15, 2075-2079.
149. Tattersall, M.H.N., M. Jarman, E.S. Newlands, L. Holyhead, R.A.V. Milstead and A. Weinberg (1978) Pharmacokinetics of melphalan following oral or intravenous administration in patients with malignant disease, Eur. J. Cancer, 14, 507-513.
150. Teng, S.P., S.A. Woodson and D.M. Crothers (1989) DNA sequence specificity of mitomycin cross-linking, Biochemistry, 28, 3901-3907.
151. Terheggen, P.M.A.B., A.C. Begg, J.Y. Emondt, R. Dubbelman, B.G.J. Floot and L. den Engelse (1991) Formation of interaction products of carboplatin with DNA in vitro and in cancer patients, Br. J. Cancer 63, 195-200.
152. Tilby, M.J., J.M. Styles and C.J. Dean (1987) Immunological detection of DNA damage caused by melphalan using monoclonal antibodies, Cancer Res., 47, 1542-1546.
153. Tilby, M.J., P.D. Lawley and P.B. Farmer (1990) Alkylation of DNA by melphalan in relation to immunoassay of melphalan-DNA adducts: characterization of monoalkylated and cross-linked products from reaction of melphalan with dGMP and GMP, Chem.-Biol. Interactions, 73, 183-194.
154. Tilby, M.J., D.R. Newell, C. Viner, P.J. Selby and C.J. Dean (1993) Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy, Eur. J. Cancer, 29A, 681-686.
155. Tilby, M.J., H. McCartney, J. Cordell, A.J. Frank and C.J. Dean (1995) A monoclonal antibody that recognises alkali-stabilized melphalan-DNA adducts and its application in immunofluorescence microscopy, Carcinogenesis, 16, 1895-1901.
156. Tomasz, M. (1994) DNA adducts of the mitomycins, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar, D. Segerback and H. Bartsch (Eds.). DNA Adducts: Identification and Biological Significance, IARC Scientific Publication No. 125, IARC, Lyon, pp. 349-357.
157. Tong, W.P. and D.B. Ludlum (1980) Crosslinking of DNA by busulfan: formation of diguaninyl derivatives, Biochim. Biophys. Acta, 608, 174-181.
158. Tong, W.P., K.W. Kohn and D.B. Ludlum (1982) Modifications of DNA by different haloethylnitrosoureas, Cancer Res., 42, 4460-4464.
159. van Delft, J.H.M., E.J.M. van Weert, MM. Schellekens, E. Claassen and R.A. Baan (1991) The isolation of monoclonal antibodies selected for the detection of imidazole ring-opened N7-ethylguanine in purified DNA and in cells in situ. Cross-reactions with methyl, 2-hydroxyethyl and sulphur mustard adducts, Carcinogenesis, 12, 1041-1049.
160. van Delft, J.H.N., A.M.C van der Ende, H.J. Keizer, J. Ouwerkerk and R.A. Baan (1992) Determination of N7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine, Carcinogenesis, 13, 1257-1259.
161. van der Schans, G.P., A.G. Scheffer, R.H. Mars-Groenendijk, A. Fidder, H.P. Benschop and R.A. Baan (1994) Immunochemical detection of adducts of sulfur mustard to DNA of calf thymus and human white blood cells, Chem. Res. Toxicol., 7, 408-413.
162. s-1 and their removal by the resistant strain, Biochem. Biophys. Res. Commun., 31, 355-360.
163. Venitt, S. (1993) Carcinogenic and genotoxic effects of antineoplastic agents, in: P.N. Plowman, T.J. McElwain and A.T. Meadows (Eds.), Complications of Cancer Management, Butterworth-Heinemann, Oxford, pp. 27-54.
164. Vistica, D.T. and M. Rabinovitz (1979) Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier system, Biochem. Biophys. Res. Commun., 86, 929-932.
165. Wakaki, S., H. Marumo, K. Tomioka, G. Shimizu, E. Kato, H. Kamada, S. Kudo and Y. Fujimoto (1958) Isolation of new fractions of antitumor mitomycins, Antibiotics and Chemotherapy, 8, 228-240.
166. Walton, M.I., D. Whysong, P.M. O'Connor, D. Hockenbery, S.J. Korsmeyer and K.W. Kohn (1993) Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis, Cancer Res., 53, 1853-1861.
167. Warren, W. and P.D. Lawtey (1980) Removal of alkyiation products from DNA of E. coli cells treated with the carcinogens N-ethyl-N-nitrosourea and N-methyl-N-nitrosourea: influence of growth conditions and DNA repair defects, Carcinogenesis, 1, 67-78.
168. Watson, J.D. and F.H.C. Crick (1953a) Molecular structure of nucleic acids. A structure for deoxyribose nucleic acids, Nature (Lond.) 171, 737-738.
169. Watson, J.D. and F.H.C. Crick (1953b) Genetical implications of the structure of deoxyribose nucleic acid. Nature (Lond.), 171, 964-967.
170. Weidner, M.F., J.T. Millard and P.B. Hopkins (1989) Determination at single nucleotide resolution of the sequence specificity of DNA interstrand crosslinking agents in DNA fragments, J. Am. Chem. Soc., 111, 9270-9272.
171. White, I.N.H., F. de Matteis, A. Davies, L.L. Smith, C. Crofton-Sleigh, S. Venitt, A. Hewer and D.H. Phillips, Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57B1/6 mice and in human MCL-5 cells, Carcinogenesis, 13, 2197-2203 (1992).
172. Yang, X.Y., V. DeLeo and R.M. Santella (1987) Immunological detection and visualization of 8-methoxypsoralen-DNA photoadducts, Cancer Res., 47, 2451-2455.
173. Yang, X.Y., F.P. Gasparro, V.A. DeLeo and R.M. Santella (1989) 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light, J. Invest. Dermatol., 92, 59-63.
174. Zwelling, L.A., T. Anderson and K.W. Kohn (1979) DNA-protein and DNA interstrand crosslinking by cis-and transplatinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res., 39, 365-369.